Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (141-150 of 435) with videos related to

Pageof 44
Sort By:
Modern Rheumatology|April 12, 2026
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: long-term efficacy and safety through 5 years in the SELECT-EARLY studyTsutomu Takeuchi, Ronald Vollenhoven, Yukitaka Ueki, et al.
The Journal of Rheumatology|August 3, 2011
It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10Vibeke Strand, Maarten Boers, Leanne Idzerda, et al.
Arthritis and Rheumatism|March 1, 1982
Antibody to cytomegalovirus in patients with Sjögren's syndrome. As determined by an enzyme-linked immunosorbent assayE J Shillitoe, T E Daniels, J P Whitcher, et al.
Arthritis Research & Therapy|October 16, 2020
Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinibVibeke Strand, Jeffrey Kaine, Rieke Alten, et al.
Rheumatology International|May 2, 2020
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritisPhilip J Mease, Iain B McInnes, Vibeke Strand, et al.
Rheumatology (Oxford, England)|October 31, 2021
A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosisMelody P Chung, Antonia Valenzuela, Shufeng Li, et al.
Arthritis and Rheumatism|March 27, 2013
Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active diseaseLaura C Coates, Oliver FitzGerald, Dafna D Gladman, et al.
The Journal of Rheumatology|February 3, 2017
The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and OutcomesDevy Zisman, Dafna D Gladman, Matthew L Stoll, et al.
Arthritis and Rheumatism|February 5, 2005
Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritisEarl Silverman, Lynn Spiegel, David Hawkins, et al.
The Journal of Rheumatology|February 4, 2014
Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseasesLesley Ann Saketkoo, Shikha Mittoo, Sid Frankel, et al.
Pageof 44

Showing results (141-150 of 435) with videos related to

Sort By:
Pageof 44
Modern Rheumatology|April 12, 2026
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: long-term efficacy and safety through 5 years in the SELECT-EARLY studyTsutomu Takeuchi, Ronald Vollenhoven, Yukitaka Ueki, et al.
The Journal of Rheumatology|August 3, 2011
It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10Vibeke Strand, Maarten Boers, Leanne Idzerda, et al.
Arthritis and Rheumatism|March 1, 1982
Antibody to cytomegalovirus in patients with Sjögren's syndrome. As determined by an enzyme-linked immunosorbent assayE J Shillitoe, T E Daniels, J P Whitcher, et al.
Arthritis Research & Therapy|October 16, 2020
Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinibVibeke Strand, Jeffrey Kaine, Rieke Alten, et al.
Rheumatology International|May 2, 2020
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritisPhilip J Mease, Iain B McInnes, Vibeke Strand, et al.
Rheumatology (Oxford, England)|October 31, 2021
A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosisMelody P Chung, Antonia Valenzuela, Shufeng Li, et al.
Arthritis and Rheumatism|March 27, 2013
Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active diseaseLaura C Coates, Oliver FitzGerald, Dafna D Gladman, et al.
The Journal of Rheumatology|February 3, 2017
The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and OutcomesDevy Zisman, Dafna D Gladman, Matthew L Stoll, et al.
Arthritis and Rheumatism|February 5, 2005
Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritisEarl Silverman, Lynn Spiegel, David Hawkins, et al.
The Journal of Rheumatology|February 4, 2014
Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseasesLesley Ann Saketkoo, Shikha Mittoo, Sid Frankel, et al.
Pageof 44